Ibrahim El‐Serafi
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- CAR-T cell therapy research
Papers in
- Oncology 7
- CAR-T cell therapy research 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Moustapha Hassan (17 shared papers)Manuchehr Abedi‐Valugerdi (6 shared papers)Jonas Mattsson (13 shared papers)Heba Asem (2 shared papers)Mamoun Muhammed (2 shared papers)Khalid M. Abu–Salah (2 shared papers)Fei Ye (2 shared papers)Åsa Barrefelt (2 shared papers)
- Journals
- PLoS ONE (3 papers)International Journal of Molecular Sciences (2 papers)Scientific Reports (1 paper)Bone Marrow Transplantation (1 paper)BMC Pharmacology and Toxicology (1 paper)
- Partner nations
- SwedenUnited Arab EmiratesEgypt
In The Last Decade
Ibrahim El‐Serafi
29 papers receiving 580 citations
Peers
Comparison fields: 5 of 85
- Biomaterials 143
- Oncology 150
- Pharmacology 40
- Rehabilitation 28
- Biomedical Engineering 170
Countries citing papers authored by Ibrahim El‐Serafi
This map shows the geographic impact of Ibrahim El‐Serafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim El‐Serafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim El‐Serafi more than expected).
Fields of papers citing papers by Ibrahim El‐Serafi
This network shows the impact of papers produced by Ibrahim El‐Serafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim El‐Serafi. The network helps show where Ibrahim El‐Serafi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ibrahim El‐Serafi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 178 | |
| 2 | 2021 | 80 | |
| 3 | 2023 | 40 | |
| 4 | 2017 | 32 | |
| 5 | 2015 | 30 | |
| 6 | 2022 | 26 | |
| 7 | 2016 | 26 | |
| 8 | 2022 | 24 | |
| 9 | 2014 | 19 | |
| 10 | 2017 | 18 | |
| 11 | 2012 | 16 | |
| 12 | 2018 | 11 | |
| 13 | 2013 | 11 | |
| 14 | 2019 | 10 | |
| 15 | 2024 | 10 | |
| 16 | 2022 | 8 | |
| 17 | 2014 | 8 | |
| 18 | 2017 | 8 | |
| 19 | 2013 | 7 | |
| 20 | 2023 | 6 |
About Ibrahim El‐Serafi
Ibrahim El‐Serafi is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Hematology, having authored 30 papers that have together received 588 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Wound Healing and Treatments (3 papers), CAR-T cell therapy research (3 papers), Silk-based biomaterials and applications (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Biomaterials (143 citations), Oncology (150 citations), Pharmacology (40 citations), Rehabilitation (28 citations) and Biomedical Engineering (170 citations). Ibrahim El‐Serafi has collaborated with scholars based in Sweden, United Arab Emirates and Egypt. Frequent co-authors include Moustapha Hassan, Manuchehr Abedi‐Valugerdi, Jonas Mattsson, Heba Asem, Mamoun Muhammed, Khalid M. Abu–Salah, Fei Ye, Åsa Barrefelt, Ahmed T. El‐Serafi and Salman Alrokayan. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Scientific Reports, Bone Marrow Transplantation and BMC Pharmacology and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.